Androgen Deficiency

Treatment options for male hypogonadism - Abstract

Male hypogonadism is a common condition widely associated with the aging process.

Read more...

Efficacy and safety of long-acting intramuscular testosterone undecanoate in aging men: A randomised controlled study - Abstract

OBJECTIVE: To evaluate the efficacy and safety of long-acting i.m. testosterone undecanoate (TU) in Malaysian men with testosterone deficiency (TD).

Read more...

Prevalence of andropausal symptoms among Kuwaiti males - Abstract

Andropause is a syndrome that usually occurs during men's midlife.

Read more...

Negative association between testosterone concentration and inflammatory markers in young men: A nested cross-sectional study - Abstract

OBJECTIVE: Low grade systemic inflammation (LGSI) as well as androgen deficiency has in older men been associated with several pathologies, including cardiovascular disease (CVD).

Read more...

Functional and nutritional state in elderly men with compensated hypogonadism - Abstract

OBJECTIVES: There are few data investigating the relationship between compensated hypogonadism and functional and nutritional status of elderly individuals.

Read more...

HDL cholesterol subfractions and the effect of testosterone replacement in hypogonadism - Abstract

Metabolic disorders and cardiovascular events are increased in hypogonadism.

Read more...

Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-Month safety report - Abstract

Hypogonadism, which is highly prevalent in men with sickle cell disease (SCD), affects quality of life and causes great morbidity.

Read more...

Effects of oral testosterone undecanoate therapy on bone mineral density and body composition in 322 aging men with symptomatic testosterone deficiency: A 1-year, randomized, placebo-controlled, dose-ranging study - Abstract

Objective: We investigated the effects of oral testosterone undecanoate (TU) on bone mineral density (BMD), lean body mass (LBM) and body fat mass (BFM) in aging men with symptomatic testosterone deficiency (TD).

Read more...

Is androgen therapy indicated in men with osteoporosis? - Abstract

Male osteoporosis is not rare, and its management is a public health issue.

Read more...

Risks and benefits of testosterone therapy in older men - Abstract

In young men (defined as age < 50 years) with classic hypogonadism caused by known diseases of the hypothalamus, pituitary or testes, testosterone replacement therapy induces a number of beneficial effects, for example, the development of secondary sex characteristics, improvement and maintenance of sexual function, and increases in skeletal muscle mass and BMD.

Read more...

Page 1 of 12